Wordt geladen...
Clinical development of mTOR inhibitors in breast cancer
The mammalian target of rapamycin (mTOR) pathway is a central pathway that regulates mRNA translation, protein synthesis, glucose metabolism, lipid synthesis and autophagy, and is involved in malignant transformation. Several randomized trials have shown that the use of mTOR inhibitors could improve...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3978635/ https://ncbi.nlm.nih.gov/pubmed/25189767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3618 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|